LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.03 | 21.74 | 6596 | 6155 | 1.0716 | 1.0170 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.03 | 21.74 | 3219 | 6155 | 0.5230 | 0.8470 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.03 | 21.74 | 6344 | 6155 | 1.0306 | 1.0074 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.00 | 21.74 | 1807 | 6081 | 0.2971 | 0.7226 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.00 | 21.74 | 6567 | 6081 | 1.0798 | 1.0190 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.00 | 21.74 | 1931 | 6081 | 0.3175 | 0.7367 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.00 | 21.74 | 6725 | 6081 | 1.1058 | 1.0249 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.00 | 21.74 | 2393 | 6081 | 0.3935 | 0.7832 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.00 | 21.74 | 6513 | 6081 | 1.0710 | 1.0169 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.97 | 21.74 | 1433 | 6084 | 0.2355 | 0.6741 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.97 | 21.74 | 6737 | 6084 | 1.1073 | 1.0252 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.97 | 21.74 | 1461 | 6084 | 0.2401 | 0.6781 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.97 | 21.74 | 6830 | 6084 | 1.1225 | 1.0286 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.97 | 21.74 | 2175 | 6084 | 0.3575 | 0.7623 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 89.97 | 21.74 | 6659 | 6084 | 1.0944 | 1.0223 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.94 | 21.74 | 1066 | 6121 | 0.1741 | 0.6134 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.94 | 21.74 | 6922 | 6121 | 1.1307 | 1.0304 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.94 | 21.74 | 1280 | 6121 | 0.2091 | 0.6501 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.94 | 21.74 | 6999 | 6121 | 1.1433 | 1.0332 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.94 | 21.74 | 1451 | 6121 | 0.2370 | 0.6757 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 91.94 | 21.74 | 6729 | 6121 | 1.0992 | 1.0234 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.92 | 21.74 | 846 | 6070 | 0.1394 | 0.5693 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.92 | 21.74 | 7034 | 6070 | 1.1588 | 1.0366 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.92 | 21.74 | 721 | 6070 | 0.1188 | 0.5387 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.92 | 21.74 | 7100 | 6070 | 1.1697 | 1.0390 | MN20160310_N01 | H12 |